M-CSF: a novel plasmacytoid and conventional dendritic cell poietin

Ben Fancke1, Mark Suter, Hubertus Hochrein

  • 1Research Department, Bavarian Nordic GmbH, Martinsried, Germany.

Blood
|October 6, 2007
PubMed

Insights

Macrophage-colony-stimulating factor (M-CSF) drives plasmacytoid dendritic cell (pDC) development independently of Flt-3 ligand (FL). This finding offers new insights into immune cell generation for research and therapeutic applications.

Area of Science:

  • Immunology
  • Cell Biology
  • Hematopoiesis

Background:

  • Plasmacytoid dendritic cells (pDCs) are crucial for immune responses but are rare in vivo.
  • Flt-3 ligand (FL) culture systems enable pDC generation, with FL assumed to be the key growth factor.
  • Understanding pDC development is vital for viral infection, autoimmunity, and tolerance research.

Purpose of the Study:

  • To investigate alternative factors driving pDC development beyond FL.
  • To explore the role of macrophage-colony-stimulating factor (M-CSF) in pDC and conventional DC (cDC) generation.
  • To determine if M-CSF-driven DC development is dependent on endogenous FL.

Main Methods:

  • Generating bone marrow-derived cells in vitro using M-CSF.
  • Analyzing the phenotype and function (IFN-alpha production) of generated cells.
  • Administering M-CSF to mice in vivo and assessing DC populations.
  • Utilizing FL-deficient mice to evaluate M-CSF's role independently of FL.

Main Results:

  • M-CSF induced the development of pDCs with high interferon-alpha production capacity in vitro.
  • M-CSF also drove the development of conventional DCs (cDCs) from bone marrow precursors.
  • In vivo administration of M-CSF promoted pDC and cDC development.
  • M-CSF-driven pDC and cDC generation occurred independently of endogenous FL.

Conclusions:

  • M-CSF is a potent driver of both pDC and cDC development, in vitro and in vivo.
  • The generation of these critical immune cells by M-CSF is independent of FL signaling.
  • This discovery expands our understanding of DC hematopoiesis and offers alternative methods for generating these cells for research.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...